CASI Pharmaceuticals
CASI
#9477
Rank
S$60.2 M
Marketcap
$3.89
Share price
-5.30%
Change (1 day)
-56.76%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -S$39.52 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are S$22.05 Million. In 2023 the company made an earning of -S$35.91 Million, an increase over its 2022 earnings that were of -S$50.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$39.52 Million10.04%
2023 -S$35.91 Million-29.55%
2022 -S$50.97 Million4.43%
2021 -S$48.81 Million-24.56%
2020 -S$64.69 Million4.74%
2019 -S$61.77 Million65.13%
2018 -S$37.41 Million155.07%
2017 -S$14.67 Million13.93%
2016 -S$12.88 Million31.18%
2015 -S$9.82 Million-72.5%
2014 -S$35.68 Million356.62%
2013 -S$7.82 Million-60.55%
2012 -S$19.81 Million218.41%
2011 -S$6.22 Million0.74%
2010 -S$6.18 Million-32.54%
2009 -S$9.16 Million-66.98%
2008 -S$27.72 Million-14.22%
2007 -S$32.32 Million7.04%
2006 -S$30.19 Million27.95%
2005 -S$23.6 Million4.51%
2004 -S$22.58 Million-15.84%
2003 -S$26.83 Million-55.29%
2002 -S$60 Million-34.05%
2001 -S$90.97 Million31.73%
2000 -S$69.06 Million31.56%
1999 -S$52.5 Million145.56%
1998 -S$21.38 Million76.4%
1997 -S$12.12 Million36.92%
1996 -S$8.86 Million